awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33654306-1F12F5C8-0CEC-4DB3-A529-8B5B3BEBA6F4
Q33654306-1F12F5C8-0CEC-4DB3-A529-8B5B3BEBA6F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33654306-1F12F5C8-0CEC-4DB3-A529-8B5B3BEBA6F4
Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?
P2860
Q33654306-1F12F5C8-0CEC-4DB3-A529-8B5B3BEBA6F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33654306-1F12F5C8-0CEC-4DB3-A529-8B5B3BEBA6F4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10c05808d69efe05cddf97c7711a02f70353e71c
P2860
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control.